Technological advances, growth in surgical procedures, and the aging population, amongst other factors, are driving the dynamic shifts occurring within the Sternal Closure Systems Market. One of the major causes for this dynamism is the increased prevalence of cardiovascular diseases, which leads to more cardiac surgeries needed to be done on patients affected by these diseases. The increase in lifestyle-based issues along with an aged population results in an exponential rise in cardiovascular disorders, thereby creating robust terminal closure systems markets. These systems play an important role in stabilizing post-surgery sternum, reducing complications and risks, and hence enhancing patient outcomes.
Furthermore, technical innovation has helped alter the landscape of sternal closure systems. The effectiveness and safety of these systems have greatly improved through innovations in materials, design, and manufacturing processes. Moreover, market dynamics are further affected by the growing adoption of minimally invasive surgical methods. Sternal closure systems have to adjust to these preferences as surgeons and patients search for less invasive options. Minimally invasive surgeries result in small incisions with low pain levels and faster healing times. Therefore, such procedures call for sternum closing systems that can be used with them; hence, this is increasing demand in the market, thereby prompting companies to invest in R&D for more flexible products.
Sternal closure system dynamics have also been influenced by globalization. This has expanded the market reach due to increased access to advanced medical procedures and technologies in developing countries. These regions' demands for sternal closure systems are increasing due to high healthcare awareness levels, rising disposable incomes, and improved healthcare facilities. On a regulatory front, stringent quality and safety standards continue to shape Sternal Closure System markets. Compliance with regulatory guidelines is necessary for manufacturers seeking market approval and building trust among healthcare providers and patients. This regulatory environment encourages constant improvement and innovation and hence acts as a driving force behind the evolution of sternal closure systems.
Sternal Closure Systems Market Size was valued at USD 1.9 billion in 2022. The Sternal Closure Systems market industry is projected to grow from USD 2.0045 Billion in 2023 to USD 2.72 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.5% during the forecast period (2023 - 2032).
One of the main factors driving the market's growth is the growing number of older adults having open-heart surgery through a median sternotomy. Due to its simplicity and speedy access to the heart's valves and blood vessels, the median sternotomy operation has remained the most widely used method for cardiac exposure, thus driving the growth of the Sternal Closure Systems market. These are just a few of the market drivers that are driving the market.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Abyrx, a market player, achieved expanded FDA approval for its moldable bone putty, MONTAGE, in September 2023. With this new approval, the product can now be used in cardiothoracic surgery following sternotomy and is thus designed to improve sternal repair and closure by cardiac surgeons.
In May 2022, KPOWER, a subsidiary of Granulab, introduced Prosteomax, which is halal-certified synthetic bone cement in Malaysia that can be applied for dental, orthopedics, cranial and maxillofacial.
For example, In February 2022, Evonik Venture Capital invested in a U.S.-based start-up called CircumFix Solutions, which has developed an innovative sternal closure instrument that helps patients recover faster after open heart surgery. This device is made from high-performance polymer and secures the sternum after surgery.
The ValkyrieTM Thoracic Fixation System was launched by Able Medical Devices in June 2021. It is the first radiolucent plating system on the market designed as single-use only specifically for cases of open-heart surgery with osteotomy bridgingandsternum valve sealing
Montage Bone Putty (MBP) is a pipeline medical product from Abyrx Inc. Settable, re-absorbable hemostatic bone putty is currently undergoing Phase 2 clinical trials to compare how well patients with medical sternotomies heal after surgery using montage putty and conventional wires vs. traditional wires alone.
In the year 2020, WEGO-STAINLESS STEEL, which was approved by the US Food and Drug Administration (FDA) through the 510(k) process as provided for by Foosin Medical Supplies Inc., Ltd., is used in abdominal wound closure, hernia repair, sternal closure and orthopedic surgeries among others.
Sedentary lifestyles increased alcohol and tobacco use, and poor diet is increasing the prevalence of heart disorders. As a result, surgical operations are increasing, which will likely accelerate the use of sternal closure devices in surgeries throughout the next years. The CDC found that 28.1 million adults in the U.S. had a heart disease diagnosis in 2016.
The demand for surgical instruments has increased due to an increase in surgical procedures performed around the world. The OECD estimates that in the U.K., there were about 399,952 surgical procedures in 2012; by 2016, that number had risen to 491,604. In addition, the senior population is more at risk for heart disease due to poor nutrition and inactivity. Also, the demand for sternal closure systems is rising due to the aging population, which is more prone to chronic CVDs and is driving up the number of cardiovascular surgical procedures. Thus, this factor is driving the market CAGR.
Due to the rise in non-communicable disease burden and injuries, emerging nations are also concentrating on investing in public healthcare infrastructure, which will further increase the number of surgical procedures there. According to figures released by the World Bank, China spent USD 425.6 on healthcare per person in 2015 or 5.3% of GDP. Furthermore, according to the Plan of Health China 2030, healthcare spending will represent 6.5% to 7% of the nation's GDP by 2020. Thus, it is anticipated that this aspect will accelerate Sternal Closure Systems market revenue.
The Sternal Closure Systems market segmentation, based on product includes closure devices, bone cement. The closure devices segment held the majority share in 2022 in the Sternal Closure Systems market data. The primary causes of the segment's predominant share include increased per capita spending in developed and emerging nations and variables like product launches. Compared to bone cement, these devices have shown advantages such as reduced surgical problems and infections and a quicker recovery time. Also, boosting the category expansion shortly is likely due to the increased efforts made by major market players to launch new methods and product lines.
The Sternal Closure Systems market segmentation, based on procedure, includes median sternotomy, bilateral thoracosternotomy. The includes median sternotomy segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2032. To easily reach the heart, lungs, and surrounding structures during heart valve replacement surgery and coronary artery bypass surgery, median sternotomies are regularly performed osteotomies throughout the world. Moreover, median sternotomies lessen problems and post-operative infections, raising demand for them, hence contributing in the growth of the Sternal Closure Systems market.
Figure 2 Sternal Closure Systems Market, by Procedure, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The Sternal Closure Systems market segmentation, based on closure material includes stainless steel, and titanium. The titanium segment held the majority share in 2022 in the Sternal Closure Systems market data. Its dominance is brought about by benefits such as titanium's biocompatibility, ability to join human bones, and corrosion resistance efficiently. Also, the non-ferromagnetic quality of these materials, which enables patients with titanium implants to be safely scanned using an MRI, is accelerating their uptake in the market.
Sternal Closure Systems End-User Insights
The Sternal Closure Systems market segmentation, based on end-user, includes vegetables, fruits, flowers, others. The vegetables segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2032. The growing use of Sternal Closure Systems in hospitals and the availability of reasonably priced healthcare in clinics are related. In the next years, the requirement for new installations is anticipated to expand due to the rising number of hospital mergers and acquisitions and ophthalmology clinic purchases. It is projected that these elements will propel the segment, hence contributing in the growth of the Sternal Closure Systems market.
Sternal Closure Systems Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. European Sternal Closure Systems market accounted for USD 0.870 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. It is also projected that increased cooperative efforts made by major businesses to enhance their product offerings and guarantee high-quality standards will increase demand for systems throughout the region. For instance, the Cardiothoracic Closure division of RTI Surgical was purchased by A&E Medical Corporation in August 2017. The Cardiothoracic Closure division of RTI Surgical provides cable-based plate products such as the Tritium SPC System. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.
Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 STERNAL CLOSURE SYSTEMS MARKET SHARE BY REGION 2022 (%)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Sternal Closure Systems market accounts for the second-largest market share. The market's expansion in Europe is impacted by several reasons, including the expansion of the public healthcare system, companies' increased attention on obtaining the CE mark, and an increase in daycare surgeries, among others. Additionally, it is predicted that the market in the region will be driven by the rising incidence of osteoarthritis, rising demand for joint implants, and increased daycare surgeries. Moreover, UK Sternal Closure Systems market held the largest market share, and the Germany Sternal Closure Systems market was the fastest growing market in the region.
Asia Pacific Sternal Closure Systems Market is expected to grow at the fastest CAGR from 2022 to 2030. Large patient populations, growing healthcare infrastructure, and rising healthcare spending all contribute to the market expansion in Asia Pacific. The proportion of people 65 and older in Japan is predicted to rise from 28 percent to 38 percent in 2050, following the 2019 Revision of World Population Prospects. The prevalence of cardiovascular disorders is consequently predicted to rise significantly. Hence, sternal closure system sales will increase in the next years. Further, the China Sternal Closure Systems market held the largest market share, and the India Sternal Closure Systems market was the fastest-growing market in the region.
Sternal Closure Systems Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the Sternal Closure Systems market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Sternal Closure Systems industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the Sternal Closure Systems industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Sternal Closure Systems industry has provided medicine with some of the most significant benefits. The Sternal Closure Systems market major player such Depuy Synthes, Zimmer Biomet Holdings, Orthofix International N.V., A&E Medical, Kinamed Incorporated.
A&E Medical, established in 1968 and with its main office in Farmingdale, New Jersey, is a leading designer and manufacturer of a wide range of temporary cardiac pacing wires, including the MYO/Wire® Ultra-Thin and MYO/Wire® Ultra-Flex brands, disposable patient cables, and A&E Medical® Surgical Punch. These products include the A&E DoubleWireTM, the A&E Medical® Sternal Cable System, and the Thorecon®; Vance Street Capital purchased A&E Medical in 2016. Thornton Rigid Fixation System's 510(k) clearance from the U.S. FDA was announced by A&E Medical Company in January 2019. This tool treats fractures of the anterior chest wall, including sternal fixations and sternotomies.
Based in Science Park Zwijnaarde in Ghent, Ablynx is a biopharmaceutical business Sanofi subsidiary specializing in nanobodies' research and development. March 2021 - Montage Bone Putty, a pipeline medical product from Abyrx Inc., is a settable, re-absorbable hemostatic bone putty. It is currently undergoing Phase 2 clinical trials to compare how well cardiac patients with medical sternotomies heal after surgery using montage putty and conventional wires versus conventional wires alone.
Key Companies in the Sternal Closure Systems market includes
Sternal Closure Systems Industry Developments
May 2022 Prosteomax, a halal-certified synthetic bone cement, has been introduced by Granulab (M) Sdn Bhd, a 70%-owned subsidiary of KPower Bhd. Prosteomax was certified as halal by the Malaysian Islamic Development Department and licensed with the Malaysian Medical Device Authority for use in orthopedic, cranial, dental, and maxillofacial applications.
February 2022 CircumFix Solutions, a Tennessee-based start-up that has developed a ground-breaking sternal closure device to help patient recovery following open chest surgery, has received investment from Evonik Venture Capital.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)